FDA Greenlights Ibuprofen Oral Suspension Compounding to Help With Hospital Supply
Increased demand for ibuprofen oral suspension products due to a surge in 3 circulating viruses prompted the Agency to issue compounding guidance.
Diagnosis & Disease Information
CDC Releases Updated Guidance on Prescribing Opioid Pain Medication
The 2022 CDC Clinical Practice Guideline is intended to help clinicians weigh the benefits and risks of opioids and alternative pain treatments for outpatients.
Iheezo Ophthalmic Gel Approved for Ocular Surface Anesthesia
Iheezo is a sterile, preservative-free, single-patient use, ophthalmic gel preparation.
Posimir Now Available for Postsurgical Analgesia Following Shoulder Surgery
Posimir is a novel formulation of bupivacaine, an amide local anesthetic, designed to be administered directly into the surgical site.
Oral NaV1.8 Inhibitor VX-548 Designated Breakthrough Therapy for Severe Acute Pain
The designation was based on data from two phase 2 proof-of-concept studies that evaluated VX-548 for acute pain following abdominoplasty or bunionectomy surgery.
Novel Sciatica Treatment Provides Significant Pain Relief in Phase 3 Trial
SP-102 is a dexamethasone sodium phosphate viscous gel formulation that is administered by epidural injection.
Dexamethasone Injectable Gel Fast Tracked for Lumbosacral Radicular Pain
The designation is supported by data from the phase 3 C.L.E.A.R. trial.
Zynrelef Indication Expanded to Include More Surgical Procedures
Zynrelef is a dual-acting local anesthetic that delivers a fixed-dose combination of bupivacaine and meloxicam.
FDA to Review Acetaminophen-Ibuprofen IV Combo for Postoperative Pain
Maxigesic is a combination of acetaminophen 1000mg and ibuprofen 300mg for IV infusion.
Zynrelef Now Available for Postsurgical Analgesia for Up to 72 Hours
Zynrelef is a dual-acting local anesthetic that delivers a fixed-dose combination of bupivacaine, an amide local anesthetic, and meloxicam, an NSAID.
- Loading...
Loading...
Loading... 
Loading...